Media headlines about Clorox Company (The) (NYSE:CLX) have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Clorox Company (The) earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave press coverage about the company an impact score of 44.3357022613965 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:

Shares of Clorox Company (CLX) traded up 0.86% on Thursday, hitting $138.53. 780,125 shares of the company were exchanged. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The stock has a market capitalization of $17.88 billion, a PE ratio of 25.97 and a beta of 0.40. The firm’s 50-day moving average is $134.72 and its 200-day moving average is $135.01.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. Clorox Company (The)’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.30 earnings per share. Equities research analysts predict that Clorox Company will post $5.68 earnings per share for the current year.

Several research analysts have commented on the stock. UBS AG reissued a “sell” rating and set a $121.00 price objective (up previously from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Jefferies Group LLC reissued a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Barclays PLC reissued an “equal weight” rating and set a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Finally, BMO Capital Markets set a $150.00 price objective on shares of Clorox Company (The) and gave the company a “buy” rating in a report on Thursday, August 3rd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $129.05.

ILLEGAL ACTIVITY WARNING: “Clorox Company (The) (CLX) Receiving Somewhat Positive Media Coverage, Report Shows” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.watchlistnews.com/clorox-company-the-clx-receiving-somewhat-positive-media-coverage-report-shows/1534949.html.

In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at approximately $2,862,666.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the business’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Insiders sold a total of 21,242 shares of company stock worth $2,944,449 over the last quarter. 0.74% of the stock is currently owned by company insiders.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Insider Buying and Selling by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.